Genesco Inc. Reports Fiscal 2025 Fourth Quarter and Full Year Results
Genesco Inc. (NYSE: GCO) reported strong Q4 FY2025 results with net sales increasing 1% to $746 million. Comparable sales rose 10%, driven by Journeys' 14% increase. E-commerce sales grew 18%, representing 30% of retail sales.
Key Q4 highlights include: Operating income up 24%, gross margin improvement of 60 basis points, and GAAP EPS of $3.06 vs $1.84 last year. Non-GAAP EPS reached $3.26 compared to $2.59 in Q4 FY2024.
For full FY2025, net sales remained flat at $2.3 billion with comparable sales up 3%. E-commerce sales grew 12%, accounting for 25% of retail sales. The company achieved cost savings at the higher end of its $45-50 million target range.
Looking ahead to FY2026, Genesco expects total sales to be flat to up 1%, with adjusted diluted EPS projected between $1.30 to $1.70. The company ended Q4 with 1,278 stores, down 5% year-over-year, and zero debt.
Genesco Inc. (NYSE: GCO) ha riportato risultati solidi per il quarto trimestre dell'anno fiscale 2025, con vendite nette in aumento dell'1% a $746 milioni. Le vendite comparabili sono aumentate del 10%, trainate da un incremento del 14% di Journeys. Le vendite online sono cresciute del 18%, rappresentando il 30% delle vendite al dettaglio.
I punti salienti del quarto trimestre includono: utile operativo in aumento del 24%, miglioramento del margine lordo di 60 punti base e utile per azione GAAP di $3.06 rispetto a $1.84 dell'anno scorso. L'utile per azione non-GAAP ha raggiunto $3.26 rispetto a $2.59 nel quarto trimestre dell'anno fiscale 2024.
Per l'intero anno fiscale 2025, le vendite nette sono rimaste stabili a $2.3 miliardi, con vendite comparabili in aumento del 3%. Le vendite online sono cresciute del 12%, rappresentando il 25% delle vendite al dettaglio. L'azienda ha raggiunto risparmi sui costi nella parte alta del suo obiettivo di $45-50 milioni.
Guardando al futuro per l'anno fiscale 2026, Genesco prevede che le vendite totali rimangano stabili o aumentino dell'1%, con un utile per azione diluito rettificato previsto tra $1.30 e $1.70. L'azienda ha chiuso il quarto trimestre con 1.278 negozi, in calo del 5% rispetto all'anno precedente, e zero debito.
Genesco Inc. (NYSE: GCO) reportó resultados sólidos para el cuarto trimestre del año fiscal 2025, con ventas netas aumentando un 1% a $746 millones. Las ventas comparables crecieron un 10%, impulsadas por un aumento del 14% en Journeys. Las ventas de comercio electrónico crecieron un 18%, representando el 30% de las ventas minoristas.
Los aspectos destacados del cuarto trimestre incluyen: ingreso operativo en aumento del 24%, mejora del margen bruto de 60 puntos básicos y ganancias por acción GAAP de $3.06 frente a $1.84 del año pasado. Las ganancias por acción no-GAAP alcanzaron $3.26 en comparación con $2.59 en el cuarto trimestre del año fiscal 2024.
Para todo el año fiscal 2025, las ventas netas se mantuvieron estables en $2.3 mil millones, con ventas comparables en aumento del 3%. Las ventas de comercio electrónico crecieron un 12%, representando el 25% de las ventas minoristas. La empresa logró ahorros de costos en el extremo superior de su objetivo de $45-50 millones.
Mirando hacia el año fiscal 2026, Genesco espera que las ventas totales se mantengan estables o aumenten un 1%, con ganancias por acción diluidas ajustadas proyectadas entre $1.30 y $1.70. La empresa terminó el cuarto trimestre con 1,278 tiendas, una disminución del 5% en comparación con el año anterior, y cero deuda.
Genesco Inc. (NYSE: GCO)는 2025 회계연도 4분기 실적을 발표하며 순매출이 $746 백만으로 1% 증가했다고 보고했습니다. 비교 가능한 매출은 Journeys의 14% 증가에 힘입어 10% 상승했습니다. 전자상거래 매출은 18% 증가하여 소매 매출의 30%를 차지했습니다.
4분기의 주요 하이라이트는 다음과 같습니다: 운영 소득 24% 증가, 총 마진 60bp 개선, GAAP 주당순이익이 작년 $1.84에 비해 $3.06로 증가했습니다. 비-GAAP 주당순이익은 2024 회계연도 4분기 $2.59에 비해 $3.26에 도달했습니다.
2025 회계연도 전체에 대해 순매출은 $2.3 billion으로 변동 없이 유지되었으며, 비교 가능한 매출은 3% 증가했습니다. 전자상거래 매출은 12% 증가하여 소매 매출의 25%를 차지했습니다. 회사는 $45-50 백만 달러 목표 범위의 상단에서 비용 절감을 달성했습니다.
2026 회계연도를 바라보며, Genesco는 총 매출이 변동 없이 1% 증가할 것으로 예상하며, 조정된 희석 주당순이익은 $1.30에서 $1.70 사이로 예상하고 있습니다. 회사는 4분기를 1,278개 매장으로 마감했으며, 이는 전년 대비 5% 감소하였고, 부채는 없습니다.
Genesco Inc. (NYSE: GCO) a annoncé des résultats solides pour le quatrième trimestre de l'exercice 2025, avec des ventes nettes en hausse de 1% à $746 millions. Les ventes comparables ont augmenté de 10%, soutenues par une hausse de 14% de Journeys. Les ventes en ligne ont augmenté de 18%, représentant 30% des ventes au détail.
Les points forts du quatrième trimestre comprennent : un résultat opérationnel en hausse de 24%, une amélioration de la marge brute de 60 points de base et un bénéfice par action GAAP de $3.06 contre $1.84 l'année dernière. Le bénéfice par action non-GAAP a atteint $3.26 par rapport à $2.59 au quatrième trimestre de l'exercice 2024.
Pour l'ensemble de l'exercice 2025, les ventes nettes sont restées stables à $2.3 milliards, avec des ventes comparables en hausse de 3%. Les ventes en ligne ont augmenté de 12%, représentant 25% des ventes au détail. L'entreprise a réalisé des économies de coûts dans la partie supérieure de sa fourchette cible de $45-50 millions.
En se tournant vers l'exercice 2026, Genesco s'attend à ce que les ventes totales restent stables ou augmentent de 1%, avec un bénéfice par action dilué ajusté prévu entre $1.30 et $1.70. L'entreprise a terminé le quatrième trimestre avec 1.278 magasins, en baisse de 5% par rapport à l'année précédente, et aucune dette.
Genesco Inc. (NYSE: GCO) hat starke Ergebnisse für das vierte Quartal des Geschäftsjahres 2025 berichtet, mit einem Anstieg des Nettoumsatzes um 1% auf $746 Millionen. Die vergleichbaren Umsätze stiegen um 10%, was durch einen Anstieg von 14% bei Journeys unterstützt wurde. Der E-Commerce-Umsatz wuchs um 18% und machte 30% des Einzelhandelsumsatzes aus.
Wichtige Höhepunkte des vierten Quartals sind: Betriebsergebnis um 24% gestiegen, Verbesserung der Bruttomarge um 60 Basispunkte und GAAP EPS von $3.06 im Vergleich zu $1.84 im Vorjahr. Non-GAAP EPS erreichte $3.26 im Vergleich zu $2.59 im vierten Quartal des Geschäftsjahres 2024.
Für das gesamte Geschäftsjahr 2025 blieben die Nettoumsätze mit $2.3 Milliarden stabil, während die vergleichbaren Umsätze um 3% stiegen. Der E-Commerce-Umsatz wuchs um 12% und machte 25% des Einzelhandelsumsatzes aus. Das Unternehmen erzielte Kosteneinsparungen am oberen Ende seiner Zielspanne von $45-50 Millionen.
Für das Geschäftsjahr 2026 erwartet Genesco, dass die Gesamteinnahmen stabil bleiben oder um 1% steigen, mit einem angepassten verwässerten EPS, das zwischen $1.30 und $1.70 prognostiziert wird. Das Unternehmen schloss das vierte Quartal mit 1.278 Filialen ab, was einem Rückgang von 5% im Vergleich zum Vorjahr entspricht, und hat keine Schulden.
- Q4 operating income increased 24%
- Q4 comparable sales up 10%, led by Journeys' 14% increase
- E-commerce sales grew 18% in Q4
- Gross margin improved 60 basis points in Q4
- Achieved higher-end of $45-50M cost savings target
- Zero debt at quarter end
- Full year net sales remained flat at $2.3B
- Store count decreased 5% year-over-year
- Inventory increased 12% year-over-year
- Schuh sales declined 3% in Q4
- Johnston & Murphy sales decreased 6% in Q4
Insights
Genesco's Q4 FY2025 results reveal significant operational improvements despite calendar headwinds. The company delivered 10% comparable sales growth with particularly strong performance from Journeys (+14%), their largest division. E-commerce continues to be a strategic bright spot with 18% growth, now representing 30% of retail sales.
The financial metrics show marked improvement with Q4 operating income increasing 24% year-over-year and operating margin expanding 120 basis points to 6.4% on an adjusted basis. This translated to non-GAAP EPS of $3.26, up 26% from $2.59 in Q4 FY2024.
For the full year, despite flat sales at
The cost reduction program achieved its higher-end target of
For FY2026, guidance of flat to
Genesco's Q4 results demonstrate a successful execution of their footwear-focused strategy, particularly within their Journeys brand. The 14% comparable growth at Journeys significantly outpaces the broader footwear retail market, indicating effective merchandising and customer engagement strategies.
The e-commerce acceleration to 18% growth is particularly noteworthy as it represents successful channel diversification. At 30% of retail sales, their digital penetration now exceeds industry averages for footwear retailers, positioning them well in the evolving retail landscape.
Store rationalization continues with a net reduction of 63 locations during FY2025, bringing their total to 1,278 stores (
The performance divergence between banners highlights both opportunities and challenges. While Journeys leads the recovery, Schuh (UK operations) faces more challenging market conditions with sales declining
The strategic growth initiatives implemented at Journeys are clearly bearing fruit, and management's characterization of being in the "early innings" suggests potential for continued momentum. With cost savings now embedded and their footwear focus sharpened, Genesco appears positioned for incremental margin expansion even in a modest growth environment.
--Fourth Quarter Comparable Sales Increased
--Fourth Quarter E-Commerce Comparable Sales Increased
Represented
--Operating Income Increased
Fourth Quarter Fiscal 2025 Financial Summary
-
Net sales of
(13 weeks) increased$746 million 1% compared to Q4FY24 (14 weeks) -
Comparable sales increased
10% , with stores up6% and e-commerce up18% -
E-commerce sales represented
30% of retail sales compared to27% last year - Gross margin was up 60 basis points compared to last year
-
GAAP EPS was
vs.$3.06 last year and Non-GAAP EPS was$1.84 vs.$3.26 last year 1$2.59
Fiscal 2025 Financial Summary
-
Net sales of
(52 weeks) were flat compared to FY24 (53 weeks)$2.3 billion -
Comparable sales increased
3% , with stores flat and e-commerce up12% -
E-commerce sales represented
25% of retail sales compared to23% last year -
GAAP EPS was (
) vs. ($1.80 ) last year and Non-GAAP EPS was$2.10 vs.$0.94 last year1$0.56
Mimi E. Vaughn, Genesco’s Board Chair, President and Chief Executive Officer, said, “We delivered a strong finish to the year with fourth quarter sales and gross margins exceeding expectations and operating income up meaningfully from the prior year period. Our performance was led by Journeys as the strategic growth initiatives we’ve implemented over the past 12 months fueled strong full priced selling and mid-teens comp growth. At the same time, sales trends at Schuh and Johnston & Murphy further improved with fourth quarter comps for both businesses reaching the highest level of the year.”
1Non-GAAP EPS is a non-GAAP measure and excludes a gross margin charge related to a distribution model transition in Genesco Brands Group, net of tax effect, in Fiscal 2025 and charges for severance and asset impairments, net of tax effect in the fourth quarter and year of Fiscal 2025 (“Excluded Items”). Also excludes income tax expense of |
Vaughn continued, “It is rewarding to look back and see that we accomplished the strategic priorities we outlined at the start of Fiscal 2025 and that our efforts led to improved comparable sales and enhanced profitability as the year progressed. We are in the early innings of returning Journeys and the overall company to historical rates of sales and profits, but we are heading in the right direction. We are excited about the actions we are taking to build on our momentum in Fiscal 2026 centered around our footwear focused strategy and Journeys’ strategic growth plan, and we feel confident we are positioning the business to deliver profitable growth and shareholder value over the long-term.”
Fourth Quarter Review
Net sales for the fourth quarter (13 weeks) increased
Comparable Sales |
||||
|
|
|
||
Comparable Same Store and Direct Sales: |
4QFY25 |
4QFY24 |
||
Journeys Group |
|
(5)% |
||
Schuh Group |
|
(5)% |
||
Johnston & Murphy Group |
|
|
||
Total Genesco Comparable Sales |
|
(4)% |
||
Same Store Sales |
|
(7)% |
||
Comparable Direct Sales |
|
|
The overall sales increase of
Fiscal 2025 fourth quarter gross margin was
Selling and administrative expense for the fourth quarter of Fiscal 2025 decreased 60 basis points as a percentage of sales to
Genesco’s GAAP operating income for the fourth quarter was
The effective tax rate for the quarter was
GAAP earnings from continuing operations were
Full Year Review
Net sales for Fiscal 2025 (52 weeks) were flat at
Overall sales for Fiscal 2025 compared to Fiscal 2024 increased
Gross margin for Fiscal 2025 was
Selling and administrative expense for Fiscal 2025 decreased 10 basis points as a percentage of sales to
Genesco’s GAAP operating income for Fiscal 2025 was
The effective tax rate was
GAAP loss from continuing operations was
Cash, Borrowings and Inventory
Cash as of February 1, 2025 was
Capital Expenditures and Store Activity
For the fourth quarter of Fiscal 2025, capital expenditures were
Share Repurchases
The Company did not repurchase any shares during the fourth quarter of Fiscal 2025. The Company repurchased 399,633 shares for
Cost Savings Update
The Company achieved the higher-end of its target run-rate range of
Fiscal 2026 Outlook
For Fiscal 2026, the Company:
-
Expects total sales to be flat to up
1% compared to Fiscal 2025 including a foreign exchange negative impact of approximately and closed store impact of approximately$14 million $30 million -
Expects adjusted diluted earnings per share from continuing operations in the range of
to$1.30 2$1.70 -
Guidance assumes no further share repurchases and a tax rate of
29%
Conference Call, Management Commentary and Investor Presentation
The Company has posted detailed financial commentary and a supplemental financial presentation of fourth quarter results on its website, www.genesco.com, in the investor relations section. The Company's live conference call on March 7, 2025, at 7:30 a.m. (Central time), may be accessed through the Company's website, www.genesco.com. To listen live, please go to the website at least 15 minutes early to register, download and install any necessary software.
2A reconciliation of the adjusted financial measures cited in the guidance to their corresponding measures as reported pursuant to GAAP is included in Schedule B to this press release. |
Safe Harbor Statement
This release contains forward-looking statements, including those regarding future sales, earnings, operating income, gross margins, expenses, capital expenditures, depreciation and amortization, tax rates, store openings and closures, cost reductions, and all other statements not addressing solely historical facts or present conditions. Forward-looking statements are usually identified by or are associated with such words as “intend,” “expect,” “feel,” “should,” “believe,” “anticipate,” “optimistic,” “confident” and similar terminology. Actual results could vary materially from the expectations reflected in these statements. A number of factors could cause differences. These include adjustments to projections reflected in forward-looking statements, including those resulting from weakness in store and shopping mall traffic, restrictions on operations imposed by government entities and/or landlords, changes in public safety and health requirements, and limitations on the Company’s ability to adequately staff and operate stores. Differences from expectations could also result from store closures and effects on the business as a result of the level and timing of promotional activity necessary to maintain inventories at appropriate levels; our ability to pass on price increases to our customers; the imposition of tariffs on product imported by the Company or its vendors as well as the ability and costs to move production of products in response to tariffs; the Company’s ability to obtain from suppliers products that are in-demand on a timely basis and effectively manage disruptions in product supply or distribution, including disruptions as a result of pandemics or geopolitical events, including shipping disruptions in the Red Sea; unfavorable trends in fuel costs, foreign exchange rates, foreign labor and material costs, and other factors affecting the cost of products; civil disturbances; our ability to renew our license agreements; impacts of the
About Genesco Inc.
Genesco Inc. (NYSE: GCO) is a footwear focused company with distinctively positioned retail and lifestyle brands and proven omnichannel capabilities offering customers the footwear they desire in engaging shopping environments, including 1,278 retail stores and branded e-commerce websites. Its Journeys, Little Burgundy and Schuh brands serve teens, kids and young adults with on-trend fashion footwear inspired by youth culture in the
GENESCO INC. | ||||||||||||
Condensed Consolidated Statements of Operations | ||||||||||||
(in thousands, except per share data) | ||||||||||||
(Unaudited) | ||||||||||||
Quarter 4(1) | Quarter 4(1) | |||||||||||
Feb. 1, |
% of |
Feb. 3, |
% of |
|||||||||
|
2025 |
Net Sales |
|
2024 |
Net Sales |
|||||||
Net sales | $ |
745,949 |
100.0 |
% |
$ |
738,950 |
100.0 |
% |
||||
Cost of sales |
|
396,312 |
53.1 |
% |
|
396,883 |
53.7 |
% |
||||
Gross margin |
|
349,637 |
46.9 |
% |
|
342,067 |
46.3 |
% |
||||
Selling and administrative expenses |
|
301,775 |
40.5 |
% |
|
303,549 |
41.1 |
% |
||||
Asset impairments and other, net(2) |
|
1,745 |
0.2 |
% |
|
1,206 |
0.2 |
% |
||||
Operating income |
|
46,117 |
6.2 |
% |
|
37,312 |
5.0 |
% |
||||
Other components of net periodic benefit cost |
|
86 |
0.0 |
% |
|
149 |
0.0 |
% |
||||
Interest expense, net |
|
802 |
0.1 |
% |
|
1,536 |
0.2 |
% |
||||
Earnings from continuing operations before income taxes |
|
45,229 |
6.1 |
% |
|
35,627 |
4.8 |
% |
||||
Income tax expense |
|
11,676 |
1.6 |
% |
|
15,337 |
2.1 |
% |
||||
Earnings from continuing operations |
|
33,553 |
4.5 |
% |
|
20,290 |
2.7 |
% |
||||
Gain from discontinued operations, net of tax(3) |
|
828 |
0.1 |
% |
|
6,899 |
0.9 |
% |
||||
Net Earnings | $ |
34,381 |
4.6 |
% |
$ |
27,189 |
3.7 |
% |
||||
Basic earnings per share: | ||||||||||||
Before discontinued operations | $ |
3.13 |
$ |
1.86 |
||||||||
Net earnings | $ |
3.20 |
$ |
2.49 |
||||||||
Diluted earnings per share: | ||||||||||||
Before discontinued operations | $ |
3.06 |
$ |
1.84 |
||||||||
Net earnings | $ |
3.13 |
$ |
2.47 |
||||||||
Weighted-average shares outstanding: | ||||||||||||
Basic |
|
10,736 |
|
10,911 |
||||||||
Diluted |
|
10,981 |
|
11,025 |
||||||||
(1) Quarter 4 for the 13-week period ended February 1, 2025 and the 14-week period ended February 3, 2024. | ||||||||||||
(2) Includes a |
||||||||||||
(3) The gain from discontinued operations in the fourth quarter of Fiscal 2025 and Fiscal 2024 includes a |
||||||||||||
GENESCO INC. | ||||||||||||||
Condensed Consolidated Statements of Operations | ||||||||||||||
(in thousands, except per share data) | ||||||||||||||
(Unaudited) | ||||||||||||||
Fiscal Year Ended(1) | Fiscal Year Ended(1) | |||||||||||||
Feb. 1, |
% of |
Feb. 3, |
% of |
|||||||||||
2025 |
Net Sales |
2024 |
Net Sales |
|||||||||||
Net sales | $ |
2,325,062 |
|
100.0 |
% |
$ |
2,324,624 |
|
100.0 |
% |
||||
Cost of sales |
|
1,228,249 |
|
52.8 |
% |
|
1,225,804 |
|
52.7 |
% |
||||
Gross margin(2) |
|
1,096,813 |
|
47.2 |
% |
|
1,098,820 |
|
47.3 |
% |
||||
Selling and administrative expenses |
|
1,079,653 |
|
46.4 |
% |
|
1,082,040 |
|
46.5 |
% |
||||
Goodwill impairment |
|
- |
|
0.0 |
% |
|
28,453 |
|
1.2 |
% |
||||
Asset impairments and other, net(3) |
|
3,235 |
|
0.1 |
% |
|
1,787 |
|
0.1 |
% |
||||
Operating income (loss) |
|
13,925 |
|
0.6 |
% |
|
(13,460 |
) |
-0.6 |
% |
||||
Other components of net periodic benefit cost |
|
367 |
|
0.0 |
% |
|
537 |
|
0.0 |
% |
||||
Interest expense, net |
|
4,250 |
|
0.2 |
% |
|
7,777 |
|
0.3 |
% |
||||
Earnings (loss) from continuing operations before income taxes |
|
9,308 |
|
0.4 |
% |
|
(21,774 |
) |
-0.9 |
% |
||||
Income tax expense(4) |
|
28,820 |
|
1.2 |
% |
|
1,854 |
|
0.1 |
% |
||||
Loss from continuing operations |
|
(19,512 |
) |
-0.8 |
% |
|
(23,628 |
) |
-1.0 |
% |
||||
Gain from discontinued operations, net of tax(5) |
|
622 |
|
0.0 |
% |
|
6,801 |
|
0.3 |
% |
||||
Net Loss | $ |
(18,890 |
) |
-0.8 |
% |
$ |
(16,827 |
) |
-0.7 |
% |
||||
Basic loss per share: | ||||||||||||||
Before discontinued operations | $ |
(1.80 |
) |
$ |
(2.10 |
) |
||||||||
Net loss | $ |
(1.74 |
) |
$ |
(1.50 |
) |
||||||||
Diluted loss per share: | ||||||||||||||
Before discontinued operations | $ |
(1.80 |
) |
$ |
(2.10 |
) |
||||||||
Net loss | $ |
(1.74 |
) |
$ |
(1.50 |
) |
||||||||
Weighted-average shares outstanding: | ||||||||||||||
Basic |
|
10,836 |
|
|
11,243 |
|
||||||||
Diluted |
|
10,836 |
|
|
11,243 |
|
||||||||
(1) Fiscal 2025 for the 52-week period ended February 1, 2025 and Fiscal 2024 for the 53-week period ended February 3, 2024. | ||||||||||||||
(2) Includes a |
||||||||||||||
(3) Includes a |
||||||||||||||
(4) Includes a |
||||||||||||||
(5) The gain from discontinued operations in Fiscal 2025 and Fiscal 2024 includes a |
||||||||||||||
GENESCO INC. | ||||||||||||||
Sales/Earnings Summary by Segment | ||||||||||||||
(in thousands) | ||||||||||||||
(Unaudited) | ||||||||||||||
Quarter 4(1) | Quarter 4(1) | |||||||||||||
Feb. 1, |
% of |
Feb. 3, |
% of |
|||||||||||
2025 |
Net Sales |
2024 |
Net Sales |
|||||||||||
Sales: | ||||||||||||||
Journeys Group | $ |
478,114 |
|
64.1 |
% |
$ |
455,003 |
|
61.6 |
% |
||||
Schuh Group |
|
141,155 |
|
18.9 |
% |
|
146,131 |
|
19.8 |
% |
||||
Johnston & Murphy Group |
|
91,501 |
|
12.3 |
% |
|
97,623 |
|
13.2 |
% |
||||
Genesco Brands Group |
|
35,179 |
|
4.7 |
% |
|
40,193 |
|
5.4 |
% |
||||
Net Sales | $ |
745,949 |
|
100.0 |
% |
$ |
738,950 |
|
100.0 |
% |
||||
Operating Income (Loss): | ||||||||||||||
Journeys Group | $ |
43,152 |
|
9.0 |
% |
$ |
32,337 |
|
7.1 |
% |
||||
Schuh Group |
|
5,637 |
|
4.0 |
% |
|
9,325 |
|
6.4 |
% |
||||
Johnston & Murphy Group |
|
6,555 |
|
7.2 |
% |
|
6,136 |
|
6.3 |
% |
||||
Genesco Brands Group |
|
1,391 |
|
4.0 |
% |
|
(267 |
) |
-0.7 |
% |
||||
Corporate and Other(2) |
|
(10,618 |
) |
-1.4 |
% |
|
(10,219 |
) |
-1.4 |
% |
||||
Operating income |
|
46,117 |
|
6.2 |
% |
|
37,312 |
|
5.0 |
% |
||||
Other components of net periodic benefit cost |
|
86 |
|
0.0 |
% |
|
149 |
|
0.0 |
% |
||||
Interest, net |
|
802 |
|
0.1 |
% |
|
1,536 |
|
0.2 |
% |
||||
Earnings from continuing operations before income taxes |
|
45,229 |
|
6.1 |
% |
|
35,627 |
|
4.8 |
% |
||||
Income tax expense |
|
11,676 |
|
1.6 |
% |
|
15,337 |
|
2.1 |
% |
||||
Earnings from continuing operations |
|
33,553 |
|
4.5 |
% |
|
20,290 |
|
2.7 |
% |
||||
Gain from discontinued operations, net of tax(3) |
|
828 |
|
0.1 |
% |
|
6,899 |
|
0.9 |
% |
||||
Net Earnings | $ |
34,381 |
|
4.6 |
% |
$ |
27,189 |
|
3.7 |
% |
||||
(1) Quarter 4 for the 13-week period ended February 1, 2025 and the 14-week period ended February 3, 2024. | ||||||||||||||
(2) Includes a |
||||||||||||||
(3) The gain from discontinued operations in the fourth quarter of Fiscal 2025 and Fiscal 2024 includes a |
||||||||||||||
GENESCO INC. | ||||||||||||||
Sales/Earnings Summary by Segment | ||||||||||||||
(in thousands) | ||||||||||||||
(Unaudited) | ||||||||||||||
Fiscal Year Ended(1) | Fiscal Year Ended(1) | |||||||||||||
Feb. 1, |
% of |
Feb. 3, |
% of |
|||||||||||
2025 |
Net Sales |
2024 |
Net Sales |
|||||||||||
Sales: | ||||||||||||||
Journeys Group | $ |
1,398,922 |
|
60.2 |
% |
$ |
1,363,835 |
|
58.7 |
% |
||||
Schuh Group |
|
479,891 |
|
20.6 |
% |
|
480,164 |
|
20.7 |
% |
||||
Johnston & Murphy Group |
|
320,208 |
|
13.8 |
% |
|
339,446 |
|
14.6 |
% |
||||
Genesco Brands Group |
|
126,041 |
|
5.4 |
% |
|
141,179 |
|
6.1 |
% |
||||
Net Sales | $ |
2,325,062 |
|
100.0 |
% |
$ |
2,324,624 |
|
100.0 |
% |
||||
Operating Income (Loss): | ||||||||||||||
Journeys Group | $ |
26,345 |
|
1.9 |
% |
$ |
11,072 |
|
0.8 |
% |
||||
Schuh Group |
|
10,199 |
|
2.1 |
% |
|
21,435 |
|
4.5 |
% |
||||
Johnston & Murphy Group |
|
8,416 |
|
2.6 |
% |
|
16,314 |
|
4.8 |
% |
||||
Genesco Brands Group(2) |
|
6,806 |
|
5.4 |
% |
|
(8 |
) |
0.0 |
% |
||||
Corporate and Other(3) |
|
(37,841 |
) |
-1.6 |
% |
|
(33,820 |
) |
-1.5 |
% |
||||
Goodwill Impairment |
|
- |
|
0.0 |
% |
|
(28,453 |
) |
-1.2 |
% |
||||
Operating income (loss) |
|
13,925 |
|
0.6 |
% |
|
(13,460 |
) |
-0.6 |
% |
||||
Other components of net periodic benefit cost |
|
367 |
|
0.0 |
% |
|
537 |
|
0.0 |
% |
||||
Interest, net |
|
4,250 |
|
0.2 |
% |
|
7,777 |
|
0.3 |
% |
||||
Earnings (loss) from continuing operations before income taxes |
|
9,308 |
|
0.4 |
% |
|
(21,774 |
) |
-0.9 |
% |
||||
Income tax expense(4) |
|
28,820 |
|
1.2 |
% |
|
1,854 |
|
0.1 |
% |
||||
Loss from continuing operations |
|
(19,512 |
) |
-0.8 |
% |
|
(23,628 |
) |
-1.0 |
% |
||||
Gain from discontinued operations, net of tax(5) |
|
622 |
|
0.0 |
% |
|
6,801 |
|
0.3 |
% |
||||
Net Loss | $ |
(18,890 |
) |
-0.8 |
% |
$ |
(16,827 |
) |
-0.7 |
% |
||||
(1) Fiscal 2025 for the 52-week period ended February 1, 2025 and Fiscal 2024 for the 53-week period ended February 3, 2024. | ||||||||||||||
(2) Includes a |
||||||||||||||
(3) Includes a |
||||||||||||||
(4) Includes a |
||||||||||||||
(5) The gain from discontinued operations in Fiscal 2025 and Fiscal 2024 includes a |
||||||||||||||
GENESCO INC. | ||||||
Condensed Consolidated Balance Sheets | ||||||
(in thousands) | ||||||
(Unaudited) | ||||||
February 1, 2025 |
February 3, 2024 |
|||||
Assets | ||||||
Cash | $ |
34,007 |
$ |
35,155 |
||
Accounts receivable |
|
48,865 |
|
53,618 |
||
Inventories |
|
425,224 |
|
378,967 |
||
Other current assets(1) |
|
100,660 |
|
39,611 |
||
Total current assets |
|
608,756 |
|
507,351 |
||
Property and equipment |
|
228,022 |
|
240,266 |
||
Operating lease right of use assets |
|
438,273 |
|
436,896 |
||
Goodwill and other intangibles |
|
34,922 |
|
36,815 |
||
Non-current prepaid income taxes |
|
- |
|
56,839 |
||
Other non-current assets |
|
25,563 |
|
51,723 |
||
Total Assets | $ |
1,335,536 |
$ |
1,329,890 |
||
Liabilities and Equity | ||||||
Accounts payable | $ |
168,077 |
$ |
114,621 |
||
Current portion operating lease liabilities |
|
124,010 |
|
129,189 |
||
Other current liabilities |
|
87,695 |
|
75,727 |
||
Total current liabilities |
|
379,782 |
|
319,537 |
||
Long-term debt |
|
- |
|
34,682 |
||
Long-term operating lease liabilities |
|
361,079 |
|
359,073 |
||
Other long-term liabilities |
|
47,705 |
|
45,396 |
||
Equity |
|
546,970 |
|
571,202 |
||
Total Liabilities and Equity | $ |
1,335,536 |
$ |
1,329,890 |
||
(1) Includes prepaid income taxes of |
GENESCO INC. | ||||||||||||||
Store Count Activity | ||||||||||||||
Balance |
Balance |
Balance |
||||||||||||
01/28/23 |
Open |
Close |
02/03/24 | Open |
Close |
02/01/25 |
||||||||
Journeys Group | 1,130 |
27 |
94 |
1,063 |
7 |
64 |
1,006 |
|||||||
Schuh Group | 122 |
3 |
3 |
122 |
4 |
2 |
124 |
|||||||
Johnston & Murphy Group | 158 |
2 |
4 |
156 |
1 |
9 |
148 |
|||||||
Total Retail Stores | 1,410 |
32 |
101 |
1,341 |
12 |
75 |
1,278 |
|||||||
|
GENESCO INC. | ||||||||
Store Count Activity | ||||||||
Balance |
Balance |
|||||||
11/02/24 |
Open |
Close |
02/01/25 |
|||||
Journeys Group | 1,028 |
1 |
23 |
1,006 |
||||
Schuh Group | 122 |
2 |
0 |
124 |
||||
Johnston & Murphy Group | 152 |
1 |
5 |
148 |
||||
Total Retail Stores | 1,302 |
4 |
28 |
1,278 |
||||
GENESCO INC. | ||||||||
Comparable Sales | ||||||||
Quarter 4 | Fiscal Year Ended | |||||||
Feb. 1, |
Feb. 3, |
Feb. 1, |
Feb. 3, |
|||||
2025 |
2024 |
2025 |
2024 |
|||||
Journeys Group |
|
- |
|
- |
||||
Schuh Group |
|
- |
- |
|
||||
Johnston & Murphy Group |
|
|
- |
|
||||
Total Comparable Sales |
|
- |
|
- |
||||
Same Store Sales |
|
- |
|
- |
||||
Comparable E-commerce Sales |
|
|
|
|
Schedule B | |||||||||||||||||||
Genesco Inc. | |||||||||||||||||||
Adjustments to Reported Earnings from Continuing Operations | |||||||||||||||||||
Three Months Ended February 1, 2025 and February 3, 2024 | |||||||||||||||||||
The Company believes that disclosure of earnings and earnings per share from continuing operations and operating income adjusted for the items not reflected in the previously announced expectations will be meaningful to investors, especially in light of the impact of such items on the results. | |||||||||||||||||||
Quarter 4(1) | Quarter 4(1) | ||||||||||||||||||
February 1, 2025 | February 3, 2024 | ||||||||||||||||||
Net of | Per Share | Net of | Per Share | ||||||||||||||||
In Thousands (except per share amounts) | Pretax | Tax | Amounts | Pretax | Tax | Amounts | |||||||||||||
Earnings from continuing operations, as reported | $ |
33,553 |
|
$ |
3.06 |
|
$ |
20,290 |
|
$ |
1.84 |
|
|||||||
Gross margin adjustment: | |||||||||||||||||||
Charges related to distribution model transition | $ |
- |
|
12 |
|
|
0.00 |
|
$ |
- |
|
|
- |
|
|
0.00 |
|
||
Asset impairments and other adjustments: | |||||||||||||||||||
Asset impairment charges | $ |
890 |
|
678 |
|
|
0.06 |
|
$ |
378 |
|
|
272 |
|
|
0.03 |
|
||
Severance |
|
855 |
|
668 |
|
|
0.06 |
|
|
1,095 |
|
|
820 |
|
|
0.08 |
|
||
Goodwill impairment |
|
- |
|
- |
|
|
0.00 |
|
|
- |
|
|
24 |
|
|
0.00 |
|
||
Insurance gain |
|
- |
|
- |
|
|
0.00 |
|
|
(267 |
) |
|
(200 |
) |
|
(0.02 |
) |
||
Total asset impairments and other adjustments | $ |
1,745 |
|
1,346 |
|
|
0.12 |
|
$ |
1,206 |
|
|
916 |
|
|
0.09 |
|
||
Income tax expense adjustments: | |||||||||||||||||||
Tax impact share based awards |
|
(134 |
) |
|
(0.01 |
) |
|
- |
|
|
0.00 |
|
|||||||
|
(7 |
) |
|
0.00 |
|
|
- |
|
|
0.00 |
|
||||||||
Other tax items |
|
1,038 |
|
|
0.09 |
|
|
7,313 |
|
|
0.66 |
|
|||||||
Total income tax expense adjustments |
|
897 |
|
|
0.08 |
|
|
7,313 |
|
|
0.66 |
|
|||||||
Adjusted earnings from continuing operations (2) and (3) | $ |
35,808 |
|
$ |
3.26 |
|
$ |
28,519 |
|
$ |
2.59 |
|
|||||||
(1) Quarter 4 for the 13-weeks ended February 1, 2025 and the 14-weeks ended February 3, 2024. | |||||||||||||||||||
(2) The adjusted tax rate for the fourth quarter of Fiscal 2025 and 2024 is |
|||||||||||||||||||
(3) EPS reflects 11.0 million share count for each of the fourth quarters of Fiscal 2025 and 2024 which includes common stock equivalents in both periods. |
Genesco Inc. | |||||||||
Adjustments to Reported Operating Income | |||||||||
Three Months Ended February 1, 2025 and February 3, 2024 | |||||||||
Quarter 4 - February 1, 2025 | |||||||||
Operating | Asset Impair | Adj Operating | |||||||
In Thousands | Income (Loss) | & Other Adj | Income (Loss) | ||||||
Journeys Group | $ |
43,152 |
|
$ |
- |
$ |
43,152 |
|
|
Schuh Group |
|
5,637 |
|
|
- |
|
5,637 |
|
|
Johnston & Murphy Group |
|
6,555 |
|
|
- |
|
6,555 |
|
|
Genesco Brands Group |
|
1,391 |
|
|
- |
|
1,391 |
|
|
Corporate and Other |
|
(10,618 |
) |
|
1,745 |
|
(8,873 |
) |
|
Total Operating Income | $ |
46,117 |
|
$ |
1,745 |
$ |
47,862 |
|
|
% of sales |
|
6.2 |
% |
|
6.4 |
% |
|||
Depreciation and amortization |
|
13,004 |
|
||||||
Adjusted earnings before interest, taxes, depreciation and amortization ("EBITDA")(1) | $ |
60,866 |
|
||||||
% of sales |
|
8.2 |
% |
||||||
Quarter 4 - February 3, 2024 | |||||||||
Operating | Asset Impair | Adj Operating | |||||||
In Thousands | Income (Loss) | & Other Adj | Income (Loss) | ||||||
Journeys Group | $ |
32,337 |
|
$ |
- |
$ |
32,337 |
|
|
Schuh Group |
|
9,325 |
|
|
- |
|
9,325 |
|
|
Johnston & Murphy Group |
|
6,136 |
|
|
- |
|
6,136 |
|
|
Genesco Brands Group |
|
(267 |
) |
|
- |
|
(267 |
) |
|
Corporate and Other |
|
(10,219 |
) |
|
1,206 |
|
(9,013 |
) |
|
Total Operating Income | $ |
37,312 |
|
$ |
1,206 |
$ |
38,518 |
|
|
% of sales |
|
5.0 |
% |
|
5.2 |
% |
|||
Depreciation and amortization |
|
13,992 |
|
||||||
Adjusted earnings before interest, taxes, depreciation and amortization ("EBITDA")(1) | $ |
52,510 |
|
||||||
% of sales |
|
7.1 |
% |
||||||
(1) Excludes "Other components of net periodic benefit cost" line item on the Consolidated Statements of Operations. |
Schedule B | |||||||||||||||||
Genesco Inc. | |||||||||||||||||
Adjustments to Reported Earnings (Loss) from Continuing Operations | |||||||||||||||||
Fiscal Year Ended February 1, 2025 and February 3, 2024 | |||||||||||||||||
The Company believes that disclosure of earnings (loss) and earnings (loss) per share from continuing operations and operating income (loss) adjusted for the items not reflected in the previously announced expectations will be meaningful to investors, especially in light of the impact of such items on the results. | |||||||||||||||||
Fiscal Year Ended(1) | Fiscal Year Ended(1) | ||||||||||||||||
February 1, 2025 | February 3, 2024 | ||||||||||||||||
Net of | Per Share | Net of | Per Share | ||||||||||||||
In Thousands (except per share amounts) | Pretax | Tax | Amounts | Pretax | Tax | Amounts | |||||||||||
Loss from continuing operations, as reported | $ |
(19,512 |
) |
( |
) |
$ |
(23,628 |
) |
( |
) |
|||||||
Gross margin adjustment: | |||||||||||||||||
Charges related to distribution model transition | $ |
1,750 |
|
1,345 |
|
0.12 |
|
$ |
- |
|
|
- |
|
0.00 |
|
||
Asset impairments and other adjustments: | |||||||||||||||||
Asset impairment charges | $ |
1,384 |
|
1,054 |
|
0.09 |
|
$ |
959 |
|
|
718 |
|
0.07 |
|
||
Severance |
|
1,851 |
|
1,426 |
|
0.13 |
|
|
1,095 |
|
|
820 |
|
0.07 |
|
||
Goodwill impairment |
|
- |
|
- |
|
0.00 |
|
|
28,453 |
|
|
21,882 |
|
1.93 |
|
||
Insurance gain |
|
- |
|
- |
|
0.00 |
|
|
(267 |
) |
|
(200 |
) |
(0.02 |
) |
||
Impact of additional dilutive shares |
|
- |
|
- |
|
0.03 |
|
|
- |
|
|
- |
|
0.02 |
|
||
Total asset impairments and other adjustments | $ |
3,235 |
|
2,480 |
|
0.25 |
|
$ |
30,240 |
|
|
23,220 |
|
2.07 |
|
||
Income tax expense adjustments: | |||||||||||||||||
Tax impact share based awards |
|
588 |
|
0.05 |
|
|
1,059 |
|
0.09 |
|
|||||||
|
26,243 |
|
2.39 |
|
|
- |
|
0.00 |
|
||||||||
Other tax items |
|
(804 |
) |
(0.07 |
) |
|
5,735 |
|
0.50 |
|
|||||||
Total income tax expense adjustments |
|
26,027 |
|
2.37 |
|
|
6,794 |
|
0.59 |
|
|||||||
Adjusted earnings from continuing operations (2) and (3) | $ |
10,340 |
|
|
|
$ |
6,386 |
|
|
|
|||||||
(1) Fiscal 2025 for the 52-weeks ended February 1, 2025 and Fiscal 2024 for the 53-weeks ended February 3, 2024. | |||||||||||||||||
(2) The adjusted tax rate for Fiscal 2025 and 2024 is |
|||||||||||||||||
(3) EPS reflects 11.0 million and 11.4 million share count for Fiscal 2025 and 2024, respectively, which includes common stock equivalents in both periods for adjusted earnings from continuing operations. The loss from continuing operations, as reported for both periods, excludes common stock equivalents. |
Genesco Inc. | ||||||||||
Adjustments to Reported Operating Income (Loss) and Gross Margin | ||||||||||
Fiscal Year Ended February 1, 2025 and February 3, 2024 | ||||||||||
Fiscal Year Ended February 1, 2025 | ||||||||||
Operating | Asset Impair | Adj Operating | ||||||||
In Thousands | Income (Loss) | & Other Adj | Income (Loss) | |||||||
Journeys Group | $ |
26,345 |
|
$ |
- |
|
$ |
26,345 |
|
|
Schuh Group |
|
10,199 |
|
|
- |
|
|
10,199 |
|
|
Johnston & Murphy Group |
|
8,416 |
|
|
- |
|
|
8,416 |
|
|
Genesco Brands Group |
|
6,806 |
|
|
1,750 |
|
|
8,556 |
|
|
Corporate and Other |
|
(37,841 |
) |
|
3,235 |
|
|
(34,606 |
) |
|
Total Operating Income | $ |
13,925 |
|
$ |
4,985 |
|
$ |
18,910 |
|
|
% of sales |
|
0.6 |
% |
|
0.8 |
% |
||||
Depreciation and amortization |
|
52,464 |
|
|||||||
Adjusted earnings before interest, taxes, depreciation and amortization ("EBITDA")(1) | $ |
71,374 |
|
|||||||
% of sales |
|
3.1 |
% |
|||||||
Fiscal Year Ended February 3, 2024 | ||||||||||
Operating | Asset Impair | Adj Operating | ||||||||
In Thousands | Income (Loss) | & Other Adj | Income (Loss) | |||||||
Journeys Group | $ |
11,072 |
|
$ |
- |
|
$ |
11,072 |
|
|
Schuh Group |
|
21,435 |
|
|
- |
|
|
21,435 |
|
|
Johnston & Murphy Group |
|
16,314 |
|
|
- |
|
|
16,314 |
|
|
Genesco Brands Group |
|
(8 |
) |
|
- |
|
|
(8 |
) |
|
Goodwill Impairment |
|
(28,453 |
) |
|
28,453 |
|
|
- |
|
|
Corporate and Other |
|
(33,820 |
) |
|
1,787 |
|
|
(32,033 |
) |
|
Total Operating Income (Loss) | $ |
(13,460 |
) |
$ |
30,240 |
|
$ |
16,780 |
|
|
% of sales |
|
-0.6 |
% |
|
0.7 |
% |
||||
Depreciation and amortization |
|
49,441 |
|
|||||||
Adjusted earnings before interest, taxes, depreciation and amortization ("EBITDA")(1) | $ |
66,221 |
|
|||||||
% of sales |
|
2.8 |
% |
|||||||
(1) Excludes "Other components of net periodic benefit cost" line item on the Consolidated Statements of Operations. | ||||||||||
Fiscal Year Ended | ||||||||||
In Thousands | Feb. 1, 2025 | Feb. 3, 2024 | ||||||||
Gross margin, as reported | $ |
1,096,813 |
|
$ |
1,098,820 |
|
||||
% of sales |
|
47.2 |
% |
|
47.3 |
% |
||||
Charges related to distribution model transition |
|
1,750 |
|
|
- |
|
||||
Total adjustments |
|
1,750 |
|
|
- |
|
||||
Adjusted gross margin | $ |
1,098,563 |
|
$ |
1,098,820 |
|
||||
% of sales |
|
47.2 |
% |
|
47.3 |
% |
Schedule B | |||||||||
Genesco Inc. | |||||||||
Adjustments to Forecasted Earnings from Continuing Operations | |||||||||
Fiscal Year Ending January 31, 2026 | |||||||||
In millions (except per share amounts) | High Guidance | Low Guidance | |||||||
Fiscal 2026 | Fiscal 2026 | ||||||||
Net of Tax | Per Share | Net of Tax | Per Share | ||||||
Forecasted earnings from continuing operations | $ |
18.2 |
$ |
1.61 |
$ |
13.2 |
$ |
1.18 |
|
Asset impairments and other adjustments: | |||||||||
Asset impairments and other matters |
|
1.0 |
|
0.09 |
|
1.4 |
|
0.12 |
|
Total asset impairments and other adjustments (1) |
|
1.0 |
|
0.09 |
|
1.4 |
|
0.12 |
|
Adjusted forecasted earnings from continuing operations (2) | $ |
19.2 |
$ |
1.70 |
$ |
14.6 |
$ |
1.30 |
|
(1) All adjustments are net of tax where applicable. The forecasted tax rate for Fiscal 2026 is approximately |
|||||||||
(2) EPS reflects 11.3 million share count for Fiscal 2026 which includes common stock equivalents. | |||||||||
This reconciliation reflects estimates and current expectations of future results. Actual results may vary materially from these expectations and estimates, for reasons including those included in the discussion of forward-looking statements elsewhere in this release. The Company disclaims any obligation to update such expectations and estimates. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20250306804702/en/
Genesco Financial Contacts
Sandra Harris, SVP Finance, Chief Financial Officer
(615) 367-7578 / SHarris2@genesco.com
Genesco Media Contact
Claire S. McCall, Director, Corporate Relations
(615) 367-8283 / cmccall@genesco.com
Source: Genesco Inc.